Download image:

Jenny L. Wiley

Senior Fellow, Behavioral Pharmacology

Jenny Wiley, PhD, is a leading expert in behavioral pharmacology who has worked extensively with various multidisciplinary and multi-institutional teams focused on studies that use a wide range of methods from molecular to behavioral.

Dr. Wiley designs and supervises a program of in vivo research that complements existing strengths of the Center for Discovery and Analytical Sciences, including the synthesis and development of candidate medications and investigation of neural mechanisms underlying substance abuse. She also conducts independent National Institutes of Health grant-supported research in the area of cannabinoid pharmacology, an area in which she has an extensive record of peer-reviewed publications.

Before joining RTI in March 2010, Dr. Wiley was a professor in the Department of Pharmacology and Toxicology at VCU, where she still maintains an affiliate appointment. Additionally, she has been involved in governance of the International Cannabinoid Research Society for many years and served as the Society’s president at the 2013 meeting.


Postdoctoral Fellowship, Pharmacology, Virginia Commonwealth University; PhD, Biological Psychology, Virginia Commonwealth University; MS, Biological Psychology, Virginia Commonwealth University; BS, Psychology (minor: English), College of William and Mary.

Latest Publications

Evaluation of sex differences in cannabinoid dependence — Drug and Alcohol Dependence
Marusich, J.A., Lefever, T.W., Antonazzo, K.R., Craft, R.M., & Wiley, J.L. (Apr 2014)
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569 — Biochemical Pharmacology
Gamage, T.F., Ignatowska-Jankowska, B.M., Wiley, J.L., Abdelrahman, M., Trembleau, L., Greig, I.R., et al. (Apr 2014)
Pharmacology of novel synthetic stimulants structurally related to the 'bath salts' constituent 3,4-methylenedioxypyrovalerone (MDPV) — Neuropharmacology
Marusich, J.A., Antonazzo, K.R., Wiley, J.L., Blough, B.E., Partilla, J.S., & Baumann, M.H. (Mar 2014)
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model — Pharmacology, Biochemistry, and Behavior
Lefever, T.W., Marusich, J.A., Antonazzo, K.R., & Wiley, J.L. (Mar 2014)
In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: Antinociceptive activity without cannabimimetic side effects — British Journal of Pharmacology
Ignatowska-Jankowska, B.M., Ghosh, S., Crowe, M.S., Kinsey, S.G., Niphakis, M.J., Abdullah, R.A., Tao, Q., O'Neal, S.T., Walentiny, D.M., Wiley, J.L., et al. (Mar 2014)
View all publications by Jenny L. Wiley (155)


  • Cannabinoid Pharmacology
  • Behavioral Pharmacology
  • Neuropharmacology
  • Animal Models of Substance Abuse